Literature DB >> 27672436

SLC Transporters: Structure, Function, and Drug Discovery.

Claire Colas1, Peter Man-Un Ung1, Avner Schlessinger2.   

Abstract

The human Solute Carrier (SLC) transporters are important targets for drug development. Structure-based drug discovery for SLC transporters requires the description of their structure, dynamics, and mechanism of interaction with small molecule ligands and ions. The recent determination of atomic structures of human SLC transporters and their homologs, combined with improved computational power and prediction methods have led to an increased applicability of structure-based drug design methods for human SLC members. In this review, we provide an overview of the SLC transporters' structures and transport mechanisms. We then describe computational techniques, such as homology modeling and virtual screening that are emerging as key tools to discover chemical probes for human SLC members. We illustrate the utility of these methods by presenting case studies in which rational integration of computation and experiment was used to characterize SLC members that transport key nutrients and metabolites, including the amino acid transporters LAT-1 and ASCT2, the SLC13 family of citric acid cycle intermediate transporters, and the glucose transporter GLUT1. We conclude with a brief discussion about future directions in structure-based drug discovery for the human SLC superfamily, one of the most structurally and functionally diverse protein families in human.

Entities:  

Year:  2016        PMID: 27672436      PMCID: PMC5034948          DOI: 10.1039/C6MD00005C

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  130 in total

1.  Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4.

Authors:  Michael M Mysinger; Dahlia R Weiss; Joshua J Ziarek; Stéphanie Gravel; Allison K Doak; Joel Karpiak; Nikolaus Heveker; Brian K Shoichet; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

2.  Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.

Authors:  Qian Wang; Charles G Bailey; Cynthia Ng; Jessamy Tiffen; Annora Thoeng; Vineet Minhas; Melanie L Lehman; Stephen C Hendy; Grant Buchanan; Colleen C Nelson; John E J Rasko; Jeff Holst
Journal:  Cancer Res       Date:  2011-10-17       Impact factor: 12.701

3.  GLUT-1 glucose transporter is present within apical and basolateral membranes of brain epithelial interfaces and in microvascular endothelia with and without tight junctions.

Authors:  C L Farrell; J Yang; W M Pardridge
Journal:  J Histochem Cytochem       Date:  1992-02       Impact factor: 2.479

4.  Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid.

Authors:  Xiaowan Zheng; Yongmei Pan; Chayan Acharya; Peter W Swaan; James E Polli
Journal:  Bioconjug Chem       Date:  2010-10-22       Impact factor: 4.774

5.  Determinants of substrate and cation transport in the human Na+/dicarboxylate cotransporter NaDC3.

Authors:  Avner Schlessinger; Nina N Sun; Claire Colas; Ana M Pajor
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

6.  Human Na+ -coupled citrate transporter: primary structure, genomic organization, and transport function.

Authors:  Katsuhisa Inoue; Lina Zhuang; Vadivel Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

7.  Time-resolved mechanism of extracellular gate opening and substrate binding in a glutamate transporter.

Authors:  Indira H Shrivastava; Jie Jiang; Susan G Amara; Ivet Bahar
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

8.  Coupled ion binding and structural transitions along the transport cycle of glutamate transporters.

Authors:  Grégory Verdon; SeCheol Oh; Ryan N Serio; Olga Boudker
Journal:  Elife       Date:  2014-05-19       Impact factor: 8.140

9.  Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5).

Authors:  Kim Huard; Janice Brown; Jessica C Jones; Shawn Cabral; Kentaro Futatsugi; Matthew Gorgoglione; Adhiraj Lanba; Nicholas B Vera; Yimin Zhu; Qingyun Yan; Yingjiang Zhou; Cecile Vernochet; Keith Riccardi; Angela Wolford; David Pirman; Mark Niosi; Gary Aspnes; Michael Herr; Nathan E Genung; Thomas V Magee; Daniel P Uccello; Paula Loria; Li Di; James R Gosset; David Hepworth; Timothy Rolph; Jeffrey A Pfefferkorn; Derek M Erion
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

10.  Structure and mechanism of the mammalian fructose transporter GLUT5.

Authors:  Norimichi Nomura; Grégory Verdon; Hae Joo Kang; Tatsuro Shimamura; Yayoi Nomura; Yo Sonoda; Saba Abdul Hussien; Aziz Abdul Qureshi; Mathieu Coincon; Yumi Sato; Hitomi Abe; Yoshiko Nakada-Nakura; Tomoya Hino; Takatoshi Arakawa; Osamu Kusano-Arai; Hiroko Iwanari; Takeshi Murata; Takuya Kobayashi; Takao Hamakubo; Michihiro Kasahara; So Iwata; David Drew
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

View more
  62 in total

1.  A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2).

Authors:  Kelly L Damm-Ganamet; Marie-Laure Rives; Alan D Wickenden; Heather M McAllister; Taraneh Mirzadegan
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

Review 2.  The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis.

Authors:  Mohd Omar F Sikder; Shengping Yang; Vadivel Ganapathy; Yangzom D Bhutia
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

3.  Slc43a3 is a regulator of free fatty acid flux.

Authors:  Kathrin B Hasbargen; Wen-Jun Shen; Yiqiang Zhang; Xiaoming Hou; Wei Wang; Qui Shuo; David A Bernlohr; Salman Azhar; Fredric B Kraemer
Journal:  J Lipid Res       Date:  2020-03-26       Impact factor: 5.922

4.  Structural basis for amino acid exchange by a human heteromeric amino acid transporter.

Authors:  Di Wu; Tamara N Grund; Sonja Welsch; Deryck J Mills; Max Michel; Schara Safarian; Hartmut Michel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-17       Impact factor: 11.205

5.  Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.

Authors:  Qingcheng Mao; Yurong Lai; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2018-05       Impact factor: 3.922

Review 6.  Relevance of solute carrier family 5 transporter defects to inherited and acquired human disease.

Authors:  Miryam Cannizzaro; Jana Jarošová; Boel De Paepe
Journal:  J Appl Genet       Date:  2019-07-08       Impact factor: 3.240

Review 7.  Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.

Authors:  Avner Schlessinger; Matthew A Welch; Herman van Vlijmen; Ken Korzekwa; Peter W Swaan; Pär Matsson
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

Review 8.  Advances and Challenges in Rational Drug Design for SLCs.

Authors:  Rachel-Ann A Garibsingh; Avner Schlessinger
Journal:  Trends Pharmacol Sci       Date:  2019-09-10       Impact factor: 14.819

9.  Prediction of Drug Permeability Using In Vitro Blood-Brain Barrier Models with Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells.

Authors:  Makiko Ohshima; Shota Kamei; Hideo Fushimi; Shinji Mima; Tadanori Yamada; Takeshi Yamamoto
Journal:  Biores Open Access       Date:  2019-11-14

10.  Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.

Authors:  Claire Colas; Masayuki Masuda; Kazuaki Sugio; Seiji Miyauchi; Yongjun Hu; David E Smith; Avner Schlessinger
Journal:  Mol Pharm       Date:  2017-11-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.